Literature DB >> 18008123

Pulmonary hypertension due to unknown causes in liver resection.

Junji Egawa1, Satoki Inoue, Takeaki Shinjo, Hitoshi Furuya.   

Abstract

A 16-year-old male underwent transcatheter arterial embolization against a large hepatic tumor, and was subsequently scheduled for removal of the tumor. Sudden hypotension and tachycardia were observed on removal of the tumor. Massive bleeding or obstruction of the inferior vena cava was expected to develop, but this did not occur because of simultaneous pulmonary hypertension (PH). The development of acute PH due to pulmonary vasoconstriction was suspected. Milrinone and prostaglandin E1 were effective. The same type of PH was again observed during manipulation of the residual portion of the liver. The acute PH was reproducible each time the liver was manipulated, which could suggest that this series of PH was specifically related to the hepatic lesion. A necrotic hepatic lesion might play an important role in disturbing the pulmonary circulation and causing the development of acute PH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18008123     DOI: 10.1007/s00540-007-0561-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  9 in total

1.  Pulmonary vascular response to anaphylaxis in isolated canine lungs.

Authors:  T Shibamoto; T Hayashi; F Sawano; Y Saeki; Y Matsuda; M Kawamoto; S Koyama
Journal:  Am J Physiol       Date:  1992-11

Review 2.  [Pulmonary hypertensive crisis after open heart surgery].

Authors:  K Sakamoto; M Yokota; I Kyoku; M Kitano; I Shimada; T Mizuhara; H Nakano; K Ueda; A Saito; N Fukumoto
Journal:  Kyobu Geka       Date:  1989-04

3.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

Authors:  B W Christman; C D McPherson; J H Newman; G A King; G R Bernard; B M Groves; J E Loyd
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

4.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

Review 5.  The cytokine network in the critically ill.

Authors:  R Bellomo
Journal:  Anaesth Intensive Care       Date:  1992-08       Impact factor: 1.669

Review 6.  Pathology and pathophysiology of primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  Am J Cardiol       Date:  1995-01-19       Impact factor: 2.778

7.  Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.

Authors:  E S Monrad; R G McKay; D S Baim; W S Colucci; M A Fifer; G V Heller; H D Royal; W Grossman
Journal:  Circulation       Date:  1984-12       Impact factor: 29.690

8.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

9.  Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.

Authors:  C J Horvath; J E Kaplan; A B Malik
Journal:  Am Rev Respir Dis       Date:  1991-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.